GOALI: Collaborative Research: Structure, Stability, and Mechanisms of Nonnative Protein Aggregate & Microparticle Formation

0931173/0932155 Roberts/Fernandez该项目旨在为填补以下方面的关键空白奠定基础：非本地微粒与可溶性集合体的形成、集料-颗粒相分离的热力学，以及稳定集合体/粒子并控制其形态的关键相互作用。模型蛋白系统是α-糜蛋白酶原A(ACgn)和人免疫球蛋白γ-1的Fc区(IgG1-Fc)。ACgN是一个经过充分研究的起点，其基础是其已建立的可溶聚集体形成机制，以及其形成聚集体和微粒子的经验能力。IgG1-Fc是通向商业可行蛋白质的有用桥梁，因为它是一系列基于单抗(MAb)或融合结构的生物制药蛋白质的关键结构域，初步数据还表明，它很容易形成可溶性聚集体和颗粒。拟议的研究将改善对聚集和颗粒形成的机理的理解，从而为PI实验室和其他实验室未来合理设计和控制聚集阻力以及控制主要类别生物技术产品(如单抗和抗体融合蛋白)的聚集和颗粒结构/形态提供基础。合作研究计划包括来自安进的联合PI的重要学生指导和科学贡献，包括延长学生实习和定期团队会议。通过这些合作，包括在学术机构的工作，该项目将为PI实验室的研究生和本科生的教育和培训提供一个框架，重点是尖端的实验和建模工具。与以往一样，弗吉尼亚大学和密歇根大学的绩效指标将包括来自科学和工程专业代表性较低群体的学生。最后，将开发一组例子和问题，以将这项研究的各个方面纳入本科课程，包括计算和建模活动。这些模块将通过由圣何塞州立大学领导的、由弗吉尼亚州的一名PI共同开发的基于网络的教育材料存储库传播给其他教职员工。

0931173/0932155Roberts/FernandezIntellectual merit This project seeks to lay a foundation to fill key gaps in mechanistic understanding of the formation of nonnative microparticles vs. soluble aggregates, the thermodynamics of aggregate-aparticle phase separation, and key interactions that stabilize aggregates / particles and control their morphology. The model protein systems are alpha-chymotrypsinogen A (aCgn) and the Fc region of human immunoglobulin gamma-1 (IgG1-Fc). aCgn is a well-studied starting point, based on its established mechanisms of soluble aggregate formation, and its empirical ability to form both aggregates and microparticles. IgG1-Fc is a useful bridge to commercially viable proteins, as it is a key domain in a range of biopharmaceutical proteins that are based on either monoclonal antibodies (MAbs) or fusion constructs, and preliminary data also indicates it readily forms both soluble aggregates and particles.Broader impactsThe project addresses a long-standing and potentially very high impact problem in the biopharmaceutical industry. The proposed research will result in an improved mechanistic understanding of aggregation and particle formation; thereby providing a basis for future efforts in the PI's laboratories and those of others to rationally design and control aggregation resistance, as well as for control of aggregate and particle structure / morphology across major classes of biotechnology products such as MAbs and antibody-fusion proteins. The collaborative research plan involves significant student mentoring and scientific contributions from the co-PI from Amgen, including extended student internships and regular team meetings. Through these collaborations, including work in the academic institutions, this project will provide a framework for the education and training of graduate and undergraduate students in the PI's laboratories, with a specific focus on cutting-edge experimental and modeling tools. As in the past, the PIs at UVA and UD will involve students drawn from underrepresented groups in science and engineering. Finally, a set of examples and problems will be developed to incorporate aspects of this research into the undergraduate curricula, including computational and modeling activities. These modules will be disseminated to other faculty via a web-based repository of educational materials led by San Jose State University that was co-developed by one PI at Virginia.